1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
CD4+ T cells drive anti-tumor immunity elicited by in vivo dendritic cell reprogramming
- Master (Two yrs)
- 2022
-
Mark
Evaluating dendritic cell reprogramming in patient-derived cancer cells and cancer organoids
- Master (Two yrs)
- 2021
-
Mark
Using Direct Cell Reprogramming to Uncover Plasmacytoid Dendritic Cell Specification Programs and Function
- Master (Two yrs)
-
Mark
Evaluating Dendritic cell reprogramming in patient-derived tumor cells
- Master (Two yrs)
- 2020
-
Mark
Reprogramming lung carcinoma cells into antigen presenting cells
- Master (Two yrs)
-
Mark
Inducing plasmacytoid dendritic like-cells with cell reprogramming
- Master (Two yrs)
- 2019
-
Mark
Dissecting mechanisms underlying dendritic cell epigenetic reprogramming
- Master (Two yrs)